Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

DSGNDSGN
Showing 8 of 14 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in DESIGN THERAPEUTICS INC

Point72 Asset Management, L.P. holds 2.4M shares of DSGN (DESIGN THERAPEUTICS INC), worth $34.2M as of 2026-Q2. The position was decreased (-13.1% shares). DSGN represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$34.2M

Current Shares

2.4M

Total Value Change

+$25.6M

Total Shares Change

+765,713

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.4M
-13.1%
$34.2M0.0%$14.47
0
2026-Q1
Decreased
2.7M
-49.3%
$29M0.0%$10.00
0
2025-Q4
Increased
5.4M
+60.8%
$50.4M0.1%$9.79
42
2025-Q3
Increased
3.3M
+84.8%
$25.2M0.0%$6.85
44
2025-Q2
Decreased
1.8M
-0.6%
$6.1M0.0%$3.57
0
2025-Q1
Decreased
1.8M
-2.1%
$7M0.0%$4.21
0
2024-Q4
Increased
1.9M
+16.0%
$11.5M0.0%$6.17
32
2024-Q3
Increased
1.6M
+61.6%
$8.6M0.0%$5.33
40

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used